Text Size

Diffusion and Protein Corona Formation of Lipid-Based Nanoparticles in the Vitreous Humor: Profiling and Pharmacokinetic Considerations

Tavakoli S., Kari O.K., Turunen T., Lajunen T., Schmitt M., Lehtinen J., Tasaka F., Parkkila P., Ndika J., Viitala T., Alenius H., Urtti A., Subrizi A.


  • 2021
  • Molecular Pharmaceutics
View publication
  • Therapeutic Area

    Back of the eye (BOTE)

  • Technology

    Pharmacology

  • Affiliations

    Tavakoli, S., Drug Research Program, Division of Pharmaceutical Biosciences, Faculty of Pharmacy, University of Helsinki, Viikinkaari 5 E, Helsinki, 00014, Finland; Kari, O.K., Drug Research Program, Division of Pharmaceutical Biosciences, Faculty of Pharmacy, University of Helsinki, Viikinkaari 5 E, Helsinki, 00014, Finland; Turunen, T., Drug Research Program, Division of Pharmaceutical Biosciences, Faculty of Pharmacy, University of Helsinki, Viikinkaari 5 E, Helsinki, 00014, Finland; Lajunen, T., Drug Research Program, Division of Pharmaceutical Biosciences, Faculty of Pharmacy, University of Helsinki, Viikinkaari 5 E, Helsinki, 00014, Finland; Schmitt, M., Drug Research Program, Division of Pharmaceutical Biosciences, Faculty of Pharmacy, University of Helsinki, Viikinkaari 5 E, Helsinki, 00014, Finland; Lehtinen, J., Drug Research Program, Division of Pharmaceutical Biosciences, Faculty of Pharmacy, University of Helsinki, Viikinkaari 5 E, Helsinki, 00014, Finland; Tasaka, F., Pharmaceutics and Pharmacology Department, Global Rand, Santen Pharmaceutical Co., Ltd., 8916-16 Takayama-cho, Ikoma, Nara, 630-0101, Japan; Parkkila, P., Drug Research Program, Division of Pharmaceutical Biosciences, Faculty of Pharmacy, University of Helsinki, Viikinkaari 5 E, Helsinki, 00014, Finland; Ndika, J., Human Microbiome Research, Faculty of Medicine, University of Helsinki, P.O. Box 21, Helsinki, 00290, Finland; Viitala, T., Division of Pharmaceutical Chemistry and Technology, Faculty of Pharmacy, University of Helsinki, Viikinkaari 5 E, Helsinki, 00014, Finland; Alenius, H., Human Microbiome Research, Faculty of Medicine, University of Helsinki, P.O. Box 21, Helsinki, 00290, Finland, Institute of Environmental Medicine, Karolinska Institutet, Stockholm, 171 77, Sweden; Urtti, A., Drug Research Program, Division of Pharmaceutical Biosciences, Faculty of Pharmacy, University of Helsinki, Viikinkaari 5 E, Helsinki, 00014, Finland, Institute of Chemistry, St. Petersburg State University, Petergof, Universitetskii pr. 26, St. Petersburg, 198504, Russian Federation, School of Pharmacy, Faculty of Health Sciences, University of Eastern Finland, Yliopistonranta 1, Kuopio, 70210, Finland; Subrizi, A., School of Pharmacy, Faculty of Health Sciences, University of Eastern Finland, Yliopistonranta 1, Kuopio, 70210, Finland

Related Publications

Prospective natural history and clinical biomarkers of EYS-associated retinopathy in the KEYS study

Taniguchi M, Togashi Y, Yokota S, Hiraoka M, Kitahata S, Nakamura N, Yamamoto M, Mandai M, Gocho K, Toshimori M, Hirami Y, Gomi F, Kurimoto Y, Maeda A.


STudy of Atropine to Reduce (STAR) Myopia Progression in Children: 24‑Month Results of a Randomized, Double‑Masked, Vehicle‑Controlled Trial of Atropine Sulfate 0.01% and 0.03%

Korenfeld M.; Hurcikova M.; Tatsuoka K.; Cheetham J.; Kacerik M.; on behalf of the STAR Study Investigators


Consensus on evidence gaps and unmet needs in childhood myopia: findings from a European Delphi study with eye care professionals and payers

Lagreze W, Nucci P, Versteegh M, Klaver C, Barrio-Barrio J, Dahlmann-Noor A, Gomez de Liaño R, Ghorbani-Mojarrad N, Kessel L, Polling JR, Sauer A, Schuster AK, Serafino M, Villani E, Ziemssen F, Boehler YB, Capri S, Gianfrate F, Valles Callol JA, Wong O, Chen TY, Lymperopoulou C, Palaka I, Punekar Y, von Bredow D, Shi-van Wielink K.


Can't find what you're looking for?

Contact us

Document number: NP-No product-EMEA-0110
Date of preparation: February 2022